Becker's Healthcare March 5, 2024
Mariah Taylor

The FDA approved a new drug for first-line lung cancer treatment.

Amivantamab-vmjw was approved with carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer with epidermal growth...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients
HHS Secretary Kennedy Directs FDA to Explore Rulemaking to Eliminate Self-Affirmed GRAS Pathway

Share This Article